Details for Patent: 9,925,264
✉ Email this page to a colleague
Which drugs does patent 9,925,264 protect, and when does it expire?
Patent 9,925,264 protects ZTLIDO and is included in one NDA.
This patent has fourteen patent family members in eight countries.
Summary for Patent: 9,925,264
| Title: | Non-aqueous patch |
| Abstract: | Non-aqueous patches comprising lidocaine, which is not dissolved and is present in a crystalline state, have poor permeability to the skin. Therefore, non-aqueous patches have a high concentration of lidocaine. It is pointed out that lidocaine has an adverse effect on the heart. Prolonged use of a high concentration of lidocaine causes side effects, such as shock, rubor, and irritating sensation. External preparations comprising more than 5 mass % of lidocaine are designated as powerful drugs, and cannot be used as household (nonprescription) medicine. Provided is a non-aqueous patch that is effective to relieve muscle pain, the non-aqueous patch comprising lidocaine and/or its reactant, and a dissolving agent composed of an organic acid and a polyalcohol, which are contained in a base. |
| Inventor(s): | Mori; Tatsuya (Saga, JP), Saida; Naoyuki (Saga, JP) |
| Assignee: | Itochu Chemical Frontier Corporation (Tokyo, JP) Oishi Koseido Co., Ltd. (Saga, JP) |
| Application Number: | 15/065,075 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,925,264 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 9,925,264
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scilex Pharms | ZTLIDO | lidocaine | PATCH;TOPICAL | 207962-001 | Feb 28, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | METHOD FOR RELIEVING THE PAIN ASSOCIATED WITH POST-HERPETIC NEURALGIA | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,925,264
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Brazil | 112013028802 | ⤷ Try a Trial | |||
| Brazil | 122021017591 | ⤷ Try a Trial | |||
| Canada | 2835595 | ⤷ Try a Trial | |||
| European Patent Office | 2708229 | ⤷ Try a Trial | |||
| European Patent Office | 3569227 | ⤷ Try a Trial | |||
| Spain | 2743524 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
